Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
MyD88 protein destabilization mitigates NF-κB-dependent protection against macrophage apoptosis
ID
Lainšček, Duško
(
Author
),
ID
Horvat, Simon
(
Author
),
ID
Dolinar, Klemen
(
Author
),
ID
Ivanovski, Filip
(
Author
),
ID
Romih, Rok
(
Author
),
ID
Pirkmajer, Sergej
(
Author
),
ID
Jerala, Roman
(
Author
),
ID
Manček Keber, Mateja
(
Author
)
PDF - Presentation file,
Download
(2,02 MB)
MD5: C1CCF104C1B6A428A18CA9029C4669BC
URL - Source URL, Visit
https://biosignaling.biomedcentral.com/articles/10.1186/s12964-024-01930-1
Image galllery
Abstract
Various signaling pathways are essential for both the innate immune response and the maintenance of cell homeostasis, requiring coordinated interactions among them. In this study, a mutation in the caspase-1 recognition site within MyD88 abolished inflammasome-dependent negative regulation, causing phenotypic changes in mice with some similarities to human NEMO-deficiencies. The MyD88D162E mutation reduced MyD88 protein levels and colon inflammation in DSS-induced colitis mice but did not affect cytokine expression in bone marrow-derived macrophages (BMDMs). However, compared to MyD88wt counterparts, MyD88D162E BMDMs had increased oxidative stress and dysfunctional mitochondria, along with reduced prosurvival Bcl-xL and BTK expression, rendering cells more prone to apoptosis, exacerbated by ibrutinib treatment. NF-κB activation by lipopolysaccharide mitigated this sensitive phenotype. These findings underscore the importance of MyD88wt signaling for NF-κB activation, protecting against macrophage premature apoptosis at resting state. Targeting MyD88 quantity rather than just its signaling could be a promising strategy for MyD88-driven lymphoma treatment.
Language:
English
Keywords:
MyD88
,
NF-κB signaling
,
apoptosis
,
homeostasis
,
oxidative stress
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
BF - Biotechnical Faculty
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2024
Number of pages:
14 str.
Numbering:
Vol. 22, art. 549
PID:
20.500.12556/RUL-165389
UDC:
577.27
ISSN on article:
1478-811X
DOI:
10.1186/s12964-024-01930-1
COBISS.SI-ID:
215726595
Publication date in RUL:
05.12.2024
Views:
64
Downloads:
444
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Cell communication and signaling
Shortened title:
Cell commun. signal.
Publisher:
BioMed Central
ISSN:
1478-811X
COBISS.SI-ID:
513859097
Licences
License:
CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:
http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:
The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Secondary language
Language:
Slovenian
Keywords:
imunologija
,
makrofagi
,
apoptaza
,
homeostaza
,
oksidativni stres
,
MyD88
Projects
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P4-0176
Name:
Sintezna biologija in imunologija
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
J7-4640
Name:
Inovativna imunoterapija raka oreko CAR T celic (CARRS)
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
J4-4563
Name:
Uporaba izboljšanega sistema CRISPR/Cas za ne-virusno produkcijo celic CAR-T
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P3-0108
Name:
Celična biologija in molekularna genetika v biomedicini
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P3-0043
Name:
Molekularni mehanizmi razvoja in delovanja skeletne mišice
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
J7-3153
Name:
Molekularni mehanizmi specifičnosti pri uravnavanju izločanja in delovanja citokinov mišičnega izvora
Funder:
EC - European Commission
Funding programme:
HE
Project number:
101059842
Name:
Centre of Excellence for the Technologies of Gene and Cell Therapy
Acronym:
CTGCT
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back